Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization
- 1 July 1999
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 138 (1), s16-s23
- https://doi.org/10.1053/hj.1999.v138.99077
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular DiseaseJAMA, 1999
- The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapyEuropean Heart Journal, 1995
- Antithrombotic Agents in Coronary Artery DiseaseChest, 1995
- Coronary Plaque DisruptionCirculation, 1995
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactionsBiochemical Pharmacology, 1987
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.Circulation, 1987
- Platelet Membrane Glycoprotein IIb/IIIa: Member of a Family of Arg-Gly-Asp—Specific Adhesion ReceptorsScience, 1986
- Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human plateletsBlood, 1985